Skip to content

Continuous Glucose Monitoring in Prediabetes With Health Education Videos Among Community Health Workers

Continuous Glucose Monitoring in Prediabetes With Health Education Videos

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06883812
Acronym
G2
Enrollment
30
Registered
2025-03-19
Start date
2025-03-05
Completion date
2025-11-03
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prediabetes

Keywords

Prediabetes, Glucose control, Feedback, Health education, Artificial intelligence, Behavioral analysis

Brief summary

The objective of this project is to deliver a behavior health education video series that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with prediabetes. The goal is to prevent transition to type 2 diabetes and advanced metabolic complications.

Detailed description

A health education video series, ¡Mi Control!, led by community health workers known as Promotores de Salud (PdS), will be integrated with continuous glucose monitoring (CGM) to support self-monitoring of glucose levels and excursions. Study G2 is a Phase 0 feasibility study enrolling 30 Spanish- and/or English-speaking PdS who test positive for prediabetes via a finger-prick A1c% screening. Participants will wear CGM devices for 20 days, with glucose data masked for the first 10 days and unmasked for the next 10 days. During the unmasked phase, participants will receive daily health education videos on their smartphones. The study will compare the duration of glucose excursions between the masked and unmasked phases to assess the impact of CGM feedback and health education on glucose regulation.

Interventions

DEVICECGM

The CGM sensor is worn on the back of the arm and glucose levels are recorded continuously but levels are not shown on the participant's phone app in phase A.

Sponsors

David S Black, PhD
Lead SponsorOTHER
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION
Masking
NONE

Masking description

Participants are blinded to glucose values during Phase A. The CGM system generates automated records of glucose and does not require observation from an outcomes assessor. The investigator does not engage with participants and becomes aware of unmasking after trial is completed.

Intervention model description

An AB sequential condition design with CGM automated continuous glucose recording with glucose level masked and unmasked phases.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Prediabetes by finger prick blood A1C% * Centers for Disease Control and Prevention (CDC) prediabetes risk test score of 5 or higher * Willingness to wear CGM sensor * Community health worker

Exclusion criteria

* Currently pregnant * Less than 18 years of age, which is adult in California * Diagnosed with any disorder that interferes with glucose * Influential medical disorder/event affecting ability to participate in study * Incompatible smartphone device not pairing with Dexcom G6 app

Design outcomes

Primary

MeasureTime frameDescription
Glucose levelsMaximum of 20 days of continuous wearMean glucose in mg/dL

Secondary

MeasureTime frameDescription
Time out of range > 140 mg/dL (TOR)Maximum of 20 days of continuous wearTime out of range \> 140 mg/dL (TOR)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDavid S Black, PhD MPH

University of Southern California Keck School of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 7, 2026